(Q74621175)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616522%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

meta-analysis

0 references

title

The efficacy and safety of salmeterol compared to theophylline: meta-analysis of nine controlled studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616522%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

B Davies

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616522%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

G Brooks

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616522%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M Devoy

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616522%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 February 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616522%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616522%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616522%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616522%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

256-263

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616522%20AND%20SRC:MED&resulttype=core&format=json

Salmeterol xinafoate. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990105-6

7 January 2021

Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990105-6

7 January 2021

Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990105-6

7 January 2021

Methylxanthines in the Treatment of Asthma: The Rise, the Fall, and the Possible Rise Again

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990105-6

7 January 2021

Xanthines as airway anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990105-6

7 January 2021

Theophylline in the management of airflow obstruction. 2. Difficult drugs to use, few clinical indications

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990105-6

7 January 2021

Theophylline. Current thoughts on the risks and benefits of its use in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990105-6

7 January 2021

Meta-analyses of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990105-6

7 January 2021

Meta-analysis. A quantitative approach to research integration

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990105-6

7 January 2021

Comparison of inhaled salmeterol and individually dose-titrated slow-release theophylline in patients with reversible airway obstruction. European Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990105-6

7 January 2021

The efficacy and tolerability of inhaled salmeterol and individually dose-titrated, sustained-release theophylline in patients with reversible airways disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990105-6

7 January 2021

Salmeterol: an inhaled beta 2-agonist with prolonged duration of action

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990105-6

7 January 2021

Prescribing habits for theophylline preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990105-6

7 January 2021

10.1016/S0954-6111(98)90105-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9616522%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference